Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species
about
Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-LactamasesMicrobiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarityLipophilicity study of eight cephalosporins by reversed-phase thin-layer chromatographic method.Comparative analysis of antimicrobial resistance in enterotoxigenic Escherichia coli isolates from two paediatric cohort studies in Lima, Peru.Determining a clinical framework for use of cefepime and β-lactam/β-lactamase inhibitors in the treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae.High target attainment for β-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied.The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections.Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase.Evaluation of the Check-Points Check MDR CT103 and CT103 XL Microarray Kits by Use of Preparatory Rapid Cell LysisSuperiority of ceftriaxon to cefazolin in a rat model of obstructive jaundice: an experimental study.MIC-based dose adjustment: facts and fables.Impact of adopting minimum inhibitory concentration as the determinant of susceptibility to cephalosporins and carbapenems in multi-drug resistant Enterobacteriaceae.in vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam Against Resistant Gram-Negative Bacilli.Clinical Outcomes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections with Susceptibilities among Levofloxacin, Cefepime, and Carbapenems.Can the Ceftriaxone Breakpoints Be Increased Without Compromising Patient Outcomes?
P2860
Q28249617-E7880E1E-43A4-4404-ABAF-D8EDEF6BDB07Q35213565-EAA61E51-E342-4F61-BDEF-0F2BC1347316Q35635541-876DF4EE-9813-4A71-8FC5-1D0034152A3AQ36117423-E659B0D9-0F15-4D5E-B381-023ACCD16A16Q38165138-C67BDA33-C42B-4034-974F-633C936A47ACQ38792841-36572664-1C81-4252-B46C-7940B51DAA23Q38798373-CC7457CA-0613-40B6-8B24-C678F63B4430Q38864569-7F250BBA-CA22-42AD-B15E-6AAFDDA2FF0AQ40303951-3BE8CCA1-6F0A-42E9-8862-932EF1968D37Q40616765-9B6F142C-C8AA-4F00-BCC3-B562BEEDE08CQ46641706-D1EC334D-DA74-48BD-A7D0-5E4A3B3C8A04Q50027512-8357B723-D1AD-4756-B8A4-3C9187485DD8Q51008923-3CD21A42-AF4B-45F9-95CC-D49BD9C65EFDQ53682525-A745C359-3906-4597-8402-D433BC055E59Q53693902-B6E2E79F-A4EE-4D8C-B116-17AFCDF6CD1FQ55514103-1944A03B-3448-4CAD-9EF6-B7FBBEF7974B
P2860
Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Cephalosporin MIC distribution ...... ia coli and Klebsiella species
@en
Cephalosporin MIC distribution ...... ia coli and Klebsiella species
@nl
type
label
Cephalosporin MIC distribution ...... ia coli and Klebsiella species
@en
Cephalosporin MIC distribution ...... ia coli and Klebsiella species
@nl
prefLabel
Cephalosporin MIC distribution ...... ia coli and Klebsiella species
@en
Cephalosporin MIC distribution ...... ia coli and Klebsiella species
@nl
P2093
P2860
P356
P1476
Cephalosporin MIC distribution ...... ia coli and Klebsiella species
@en
P2093
Franklin R Cockerill
Peggy C Kohner
Robin Patel
P2860
P304
P356
10.1128/JCM.00508-09
P407
P577
2009-06-03T00:00:00Z